XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of company’s previously reported statement of cash flows - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Sep. 30, 2022
As Previously Reported [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income   $ 10,629,568 $ 9,186,448
Adjustments to reconcile net income to net cash used in operating activities:      
Change in fair value of derivative warrant liabilities   (5,929,000) (5,929,000)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities $ (6,037,500) (6,037,500) (6,037,500)
Income from investments held in Trust Account   (224,219) (281,713)
Changes in operating assets and liabilities:      
Prepaid expenses   57,723 75,099
Accounts payable   258,731 1,498,738
Accrued expenses   1,041,731 1,227,066
Due to related party   (29,311) (29,311)
Franchise tax payable   (70,522) (20,111)
Income tax payable   6,535 8,022
Net cash used in operating activities   (296,264) (302,262)
Supplemental disclosure of noncash financing activities:      
Extinguishment of deferred underwriting commissions allocated to Public Shares  
Restatement Adjustment [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income   (5,749,511) (5,749,511)
Adjustments to reconcile net income to net cash used in operating activities:      
Change in fair value of derivative warrant liabilities  
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities 5,749,511 5,749,511 5,749,511
Income from investments held in Trust Account  
Changes in operating assets and liabilities:      
Prepaid expenses  
Accounts payable  
Accrued expenses  
Due to related party  
Franchise tax payable  
Income tax payable  
Net cash used in operating activities  
Supplemental disclosure of noncash financing activities:      
Extinguishment of deferred underwriting commissions allocated to Public Shares   5,749,511 5,749,511
As Restated [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net income   4,880,057 3,436,937
Adjustments to reconcile net income to net cash used in operating activities:      
Change in fair value of derivative warrant liabilities   (5,929,000) (5,929,000)
Gain from extinguishment of deferred underwriting commissions allocated to derivative warrant liabilities $ (287,989) (287,989) (287,989)
Income from investments held in Trust Account   (224,219) (281,713)
Changes in operating assets and liabilities:      
Prepaid expenses   57,723 75,099
Accounts payable   258,731 1,498,738
Accrued expenses   1,041,731 1,227,066
Due to related party   (29,311) (29,311)
Franchise tax payable   (70,522) (20,111)
Income tax payable   6,535 8,022
Net cash used in operating activities   (296,264) (302,262)
Supplemental disclosure of noncash financing activities:      
Extinguishment of deferred underwriting commissions allocated to Public Shares   $ 5,749,511 $ 5,749,511